Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896505558> ?p ?o ?g. }
- W2896505558 endingPage "55" @default.
- W2896505558 startingPage "44" @default.
- W2896505558 abstract "In recent years, the number of heart valve replacements has multiplied with valve diseases because of aging populations and the surge in rheumatic heart disease in young people. Among them, bioprosthetic heart valves (BHVs) have become increasingly popular. Transcatheter aortic valve implantation (TAVI) valve as an emerging BHV has been increasingly applied to patients. However, the current commercially used BHVs treated with glutaraldehyde (Glut) still face the problem of durability. BHVs derived from Glut-treated xenogenetic tissues would undergo structural degeneration and calcification sometimes even as short as less than 10 years. This issue has already become a big challenge considering more and more young patients at the age of 50–60 s are receiving the BHV replacement. In our study, an approach that is totally different from the previous techniques named by us as the radical polymerization-crosslinking (RPC) method was developed to improve extracellular matrix stability, prevent calcification, and reduce inflammatory response in BHVs. The porcine pericardium (PP) tissue was decellularized, functionalized with methacryloyl groups, and subsequently crosslinked by radical polymerization. We found that high-density RPC treatment remarkably improved the stability of collagen and elastin of PP, enhanced its endothelialization potential, and provided reliable biomechanical performance as compared to Glut treatment. The in vivo rat model also confirmed the increased componential stability and the reduced inflammatory response of RPC-treated PP. Moreover, the RPC-treated PP showed better in vivo anticalcification potential than Glut-treated PP. Bioprosthetic heart valves (BHVs) manufactured from glutaraldehyde (Glut)-treated xenogeneic tissues have been used to treat valve-related diseases for several decades. However, the durability of BHVs remains unresolved and becomes more pronounced particularly in younger patients. Although a number of new alternative methods for Glut crosslinking have been proposed, their overall performance is still far from ready to use in humans. In this study, radical polymerization was investigated for crosslinking the porcine pericardium (PP). This treatment was found to have advantages compared to Glut-treated PP in terms of stability, biocompatibility, and anticalcification potential with the hope of addressing the needs of more robust biomaterials for the fabrication of BHVs." @default.
- W2896505558 created "2018-10-26" @default.
- W2896505558 creator A5003997033 @default.
- W2896505558 creator A5009502572 @default.
- W2896505558 creator A5014169242 @default.
- W2896505558 creator A5045818662 @default.
- W2896505558 creator A5057631682 @default.
- W2896505558 creator A5079062220 @default.
- W2896505558 date "2018-12-01" @default.
- W2896505558 modified "2023-10-14" @default.
- W2896505558 title "Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response" @default.
- W2896505558 cites W1120477740 @default.
- W2896505558 cites W1496456212 @default.
- W2896505558 cites W1543715150 @default.
- W2896505558 cites W1646061798 @default.
- W2896505558 cites W1965205816 @default.
- W2896505558 cites W1969106143 @default.
- W2896505558 cites W1970383161 @default.
- W2896505558 cites W1974538559 @default.
- W2896505558 cites W1976472429 @default.
- W2896505558 cites W1980288137 @default.
- W2896505558 cites W1987976608 @default.
- W2896505558 cites W1992718717 @default.
- W2896505558 cites W1995063875 @default.
- W2896505558 cites W1998670837 @default.
- W2896505558 cites W2002135903 @default.
- W2896505558 cites W2002762780 @default.
- W2896505558 cites W2008905610 @default.
- W2896505558 cites W2015979615 @default.
- W2896505558 cites W2026639406 @default.
- W2896505558 cites W2040438951 @default.
- W2896505558 cites W2042572296 @default.
- W2896505558 cites W2044897296 @default.
- W2896505558 cites W2046822608 @default.
- W2896505558 cites W2050150175 @default.
- W2896505558 cites W2051288112 @default.
- W2896505558 cites W2053058794 @default.
- W2896505558 cites W2053088455 @default.
- W2896505558 cites W2056292710 @default.
- W2896505558 cites W2056478347 @default.
- W2896505558 cites W2059486645 @default.
- W2896505558 cites W2064476593 @default.
- W2896505558 cites W2067321859 @default.
- W2896505558 cites W2069113830 @default.
- W2896505558 cites W2073360556 @default.
- W2896505558 cites W2077179440 @default.
- W2896505558 cites W2077443558 @default.
- W2896505558 cites W2078246403 @default.
- W2896505558 cites W2079995225 @default.
- W2896505558 cites W2080028071 @default.
- W2896505558 cites W2080166347 @default.
- W2896505558 cites W2081624455 @default.
- W2896505558 cites W2086757346 @default.
- W2896505558 cites W2086990726 @default.
- W2896505558 cites W2087380837 @default.
- W2896505558 cites W2088183342 @default.
- W2896505558 cites W2088651456 @default.
- W2896505558 cites W2099885273 @default.
- W2896505558 cites W2103722820 @default.
- W2896505558 cites W2108819369 @default.
- W2896505558 cites W2118649533 @default.
- W2896505558 cites W2118877693 @default.
- W2896505558 cites W2121902508 @default.
- W2896505558 cites W2153424827 @default.
- W2896505558 cites W2157107269 @default.
- W2896505558 cites W2160251803 @default.
- W2896505558 cites W2163122222 @default.
- W2896505558 cites W2165754900 @default.
- W2896505558 cites W2171925711 @default.
- W2896505558 cites W2332630788 @default.
- W2896505558 cites W2523640335 @default.
- W2896505558 cites W2570942768 @default.
- W2896505558 cites W2603718972 @default.
- W2896505558 cites W2620260189 @default.
- W2896505558 cites W2762789623 @default.
- W2896505558 cites W2790010649 @default.
- W2896505558 cites W2794244135 @default.
- W2896505558 cites W4232298986 @default.
- W2896505558 doi "https://doi.org/10.1016/j.actbio.2018.10.017" @default.
- W2896505558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30326277" @default.
- W2896505558 hasPublicationYear "2018" @default.
- W2896505558 type Work @default.
- W2896505558 sameAs 2896505558 @default.
- W2896505558 citedByCount "64" @default.
- W2896505558 countsByYear W28965055582019 @default.
- W2896505558 countsByYear W28965055582020 @default.
- W2896505558 countsByYear W28965055582021 @default.
- W2896505558 countsByYear W28965055582022 @default.
- W2896505558 countsByYear W28965055582023 @default.
- W2896505558 crossrefType "journal-article" @default.
- W2896505558 hasAuthorship W2896505558A5003997033 @default.
- W2896505558 hasAuthorship W2896505558A5009502572 @default.
- W2896505558 hasAuthorship W2896505558A5014169242 @default.
- W2896505558 hasAuthorship W2896505558A5045818662 @default.
- W2896505558 hasAuthorship W2896505558A5057631682 @default.
- W2896505558 hasAuthorship W2896505558A5079062220 @default.
- W2896505558 hasBestOaLocation W28965055581 @default.
- W2896505558 hasConcept C126322002 @default.